• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Chindex brokers big China sale

Article

American distribution service company Chindex International of Bethesda, MD, last month signed a letter of intent with China’s Ministry of Public Health for the purchase of up to $15 million of medical equipment. The agreement arises out of

American distribution service company Chindex International of Bethesda, MD, last month signed a letter of intent with China’s Ministry of Public Health for the purchase of up to $15 million of medical equipment. The agreement arises out of collaboration between China’s Ministry of Health Foreign Loan Office, its Ministry of Foreign Trade and Economic Cooperation, and its State Planning Commission, as well as the U.S. Department of Commerce and the U.S. Export-Import Bank.

The transaction depends on a loan guarantee from the U.S. Export-Import Bank. It is Chindex’s second loan project with the bank for U.S. medical equipment. In 1996, the firm provided $8.4 million worth of equipment to Chinese hospitals. The most recent deal includes ultrasound scanners from Acuson, bone densitometers from Lunar, transmyocardial revascularization lasers from PLC, cardiac catheterization imaging systems from Trex Medical/XRE, and clinical laboratory equipment from Johnson & Johnson Clinical Diagnostics and Nova Biomedical.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.